Q2 2021 Affimed NV Earnings Call Transcript
Good day, and welcome to Affimed's Second Quarter 2021 Financial Results and Corporate Update Conference Call. (Operator Instructions)
As a reminder, today's conference call is being recorded.
I'd now like to introduce your host for today's conference call, Alex Fudukidis, Head of Investor Relations at Affimed. Please go ahead.
Thank you, Liz. I'd like to also welcome you all for joining us today for our second quarter 2021 results and operational update call. Before we begin, I'd like to remind everyone that we issued the relevant press release earlier today and that it can be found on the Investor Relations section of our website.
On the call today, we have the following members of our management team: Dr. Adi Hoess, our Chief Executive Officer; Andreas Harstrick, our Chief Medical Officer; Arndt Schottelius, our Chief Scientific Officer; Wolfgang Fischer, our Chief Operating Officer; and Angus Smith, our Chief Financial Officer. The whole team will be available for the Q&A
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |